2030 Collaboration Life science 
Frost & Sullivan
JANUARY 16, 2023
Middle East 2023 Top 5 Trends to Watch in Healthcare & Life Sciences Industry. 2022 was the year that saw rising demand for healthcare services, an increasing focus on preventative care and wellness, and greater collaboration between the public and private sectors in the Middle East region. 2022 Round Up.
Jake Jorgovan
DECEMBER 22, 2023
Net at Work's approach ensures your technology strategy is not just current but also future-proof, preparing your business for challenges through 2030 and beyond. Consider their approach to collaboration and communication: Choose a firm that prioritizes clear and consistent communication.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
TIM Review
FEBRUARY 27, 2021
Basic digital literacy skills are thus essential for both applied sciences students and teachers. National digitalization policies for education (Higher Education Institute's Digivision 2030) offer a vision, guidelines, and resources for HE institutions in fostering digitalization and improving teachers’ digital skills. . References.
TIM Review
JUNE 28, 2021
A recent study by PwC (2020) estimates that blockchain technology has the potential to boost global GDP by $1.76 (USD) trillion by 2030 through five main areas. Blockchain: An enabler for healthcare and life sciences transformation. Blockchain and Smart Contracts for Entrepreneurial Collaboration in Maritime Supply Chains.
Frost & Sullivan
JANUARY 9, 2025
The healthcare and life sciences industries are witnessing unparalleled growth, fueled by technological advancements, shifting patient expectations, and evolving market dynamics. billion by 2030, companies like Ariceum Therapeutics and Radionetics Oncology are pioneering groundbreaking therapies that promise to improve cancer care.
Frost & Sullivan
APRIL 2, 2025
As pharmaceutical innovation continues to reshape the industry, key focuses at DCAT Week 2025 included manufacturing capacity expansion, supply chain resilience, digital transformation, and strategic collaborations. trillion in 2024, is expected to grow at a 7% CAGR through 2030.
Frost & Sullivan
OCTOBER 18, 2024
This article explores the opportunities and strategic imperatives of both topics, shedding light on how they can collaborate to drive positive change in healthcare. Life science companies will focus on omics-based research to develop effective therapies for cardiometabolic diseases.
Expert insights. Personalized for you.
52 
Let's personalize your content